Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first... Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.07 | -4.51612903226 | 1.55 | 1.6333 | 1.4 | 19580 | 1.49522293 | CS |
| 4 | -0.22 | -12.9411764706 | 1.7 | 1.8199 | 1.4 | 16793 | 1.61158599 | CS |
| 12 | -0.98 | -39.837398374 | 2.46 | 2.6 | 1.4 | 25971 | 1.95651924 | CS |
| 26 | -0.26 | -14.9425287356 | 1.74 | 3.26 | 1.4 | 33034 | 2.14050069 | CS |
| 52 | -0.05 | -3.26797385621 | 1.53 | 3.26 | 1.35 | 29267 | 2.11207276 | CS |
| 156 | -5.4692 | -78.7025844702 | 6.9492 | 7.1736 | 1.325 | 69488 | 3.78102133 | CS |
| 260 | -7.2236 | -82.9955420745 | 8.7036 | 49.2 | 1.325 | 1794284 | 19.09469946 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
